Santos David A — SEC insider filings

SEC reporting owner CIK 1820066. 20 insider filings on record with FilingPulse; latest filed 2026-09-03.

Transaction summary — filings shown

Covers all 20 filings on record, filed 2020-08-20 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
RIGEL PHARMACEUTICALS INC (RIGL)EVP, Chief Commercial Officer20—5 legs · 23,828 sh · $109,27724

Insider filings — Santos David A

FiledFormIssuerReported transactionsSource
2026-09-034RIGEL PHARMACEUTICALS INC (RIGL)Tax withholding (F): 874 @ $47.50EDGAR
2026-06-224RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 7,394 (derivative) @ $0EDGAR
2026-06-034RIGEL PHARMACEUTICALS INC (RIGL)Tax withholding (F): 874 @ $29.86EDGAR
2026-02-194RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 19,430 @ $0EDGAR
2026-02-124RIGEL PHARMACEUTICALS INC (RIGL)Tax withholding (F): 3,546 @ $34.62EDGAR
2026-02-044RIGEL PHARMACEUTICALS INC (RIGL)Tax withholding (F): 5,718 @ $36.01EDGAR
2025-09-174RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 7,394 (derivative) @ $0EDGAR
2025-03-194RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 6,875 (derivative) @ $0 · Grant/award (A): 7,850 (derivative) @ $0EDGAR
2025-02-064RIGEL PHARMACEUTICALS INC (RIGL)Sale (S): 2,125 @ $20.92 · Sale (S): 1,796 @ $21.93EDGAR
2025-01-314RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 19,717 @ $0 · Grant/award (A): 14,788 (derivative) @ $0EDGAR
2024-11-264RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 8,000 (derivative) @ $0EDGAR
2024-03-014RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 80,000 (derivative) @ $0 · Grant/award (A): 78,500 (derivative) @ $0EDGAR
2024-02-064RIGEL PHARMACEUTICALS INC (RIGL)Sale (S): 5,601 @ $1.13 · Sale (S): 8,918 @ $1.14EDGAR
2024-01-254RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 209,000 @ $0 · Grant/award (A): 157,000 (derivative) @ $0EDGAR
2023-02-064RIGEL PHARMACEUTICALS INC (RIGL)Sale (S): 5,388 @ $1.66EDGAR
2023-01-304RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 80,000 @ $0 · Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 160,000 (derivative) @ $0EDGAR
2022-12-304RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2022-01-264RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2021-01-294RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 137,500 (derivative) @ $0EDGAR
2020-08-204RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 250,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1820066 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs